Zurück
HuagongsheHuagongshe Chemie-Druckbericht · Nur für Forschungszwecke
HCID 1738Erstellt: 23. Oktober 2026

4-Hydroxy-3-methoxyphenylessigsure

HVA · Homovanilic acid · 4-HYDROXY-3-METHOXYPHENYLACETIC ACID · 4-Hydroxy-3-methoxybenzeneacetic acid · Benzeneacetic acid, 4-hydroxy-3-methoxy- · JACS-306-08-1 · homovanillicaci · Vanilacetic acid

https://huagongshe.com/de/chemical/1738

Molekülstruktur von 4-Hydroxy-3-methoxyphenylessigsure

Identifikatoren & physikalische Daten

CAS No.306-08-1
SummenformelC9H10O4
Durchschnittliche Molmasse182,17 g/mol
Monoisotopische Masse182,0579088 g/mol
SMILESCOc1cc(CC(=O)O)ccc1O
InChIKeyQRMZSPFSDQBLIX-UHFFFAOYSA-N
PubChem CID1738
ChEMBLCHEMBL1562
ChEBICHEBI:545959
EC No.206-176-7
DTXSIDDTXSID5059791
Lokaler Name4-Hydroxy-3-methoxyphenylessigsure

Chemische & physikalische Eigenschaften

XLogP0,4
Polarare Oberfläche (TPSA)66,8
H-Brücken-Donoren2
H-Brücken-Akzeptoren4
Frei drehbare Bindungen3
Schwere Atome13
Formalladung0
Komplexität180
StoffklassenBiological Agents -> Other Biomolecules
LogP (Verteilungskoeffizient)0.33
Löslichkeit17 mg/mLDMSO (Slightly), Methanol (Slightly, Heated)soluble
Schmelzpunkt138 - 140 °C142-145 °C(lit.)
Dampfdruck0.00000823 [mmHg]
Physical DescriptionWhite solid[Merck Index] White to pale brown crystalline powder[Alfa Aesar MSDS]
Collision Cross Section134.15 Ų [M-H]- [CCS Type: DTMethod: single field calibrated with Agilent tune mix (Agilent)]140.75 Ų [M-H]- [CCS Type: DTMethod: stepped-field]146.2 Ų [M+Na]+ [CCS Type: DTMethod: single field calibrated with ESI Low Concentration Tuning Mix (Agilent)]145.9 Ų [M+Na]+
Siedepunkt235.56°C (rough estimate)
Dichte1.1634 (rough estimate)
Brechungsindex1.4209 (estimate)
LagerbedingungenKeep in dark place,Inert atmosphere,Room temperature
pKa (Säurekonstante)4.39±0.10(Predicted)
AggregatzustandCrystalline Powder
FarbeWhite to beige
Merck14,4740
BRN2213447
StabilitätHygroscopic
Hauptanwendungenpharmaceutical
InChI1S/C9H10O4/c1-13-8-4-6(5-9(11)12)2-3-7(8)10/h2-4,10H,5H2,1H3,(H,11,12)
InChIKeyQRMZSPFSDQBLIX-UHFFFAOYSA-N
SMILESCOc1cc(CC(O)=O)ccc1O
LogP (Verteilungskoeffizient)0.330
CAS Datenbank306-08-1(CAS DataBase Reference)
NIST chemische InformationenBenzeneacetic acid, 4-hydroxy-3-methoxy-(306-08-1)
EPA chemische InformationenHomovanillic acid (306-08-1)

Sicherheit & Vorschriften

GHS-EinstufungWarningH315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]P261, P264, P264+P265, P271, P280, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)Aggregated GHS information provided per 46 reports by companies from 6 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Regulatorische InformationenBenzeneacetic acid, 4-hydroxy-3-methoxy-: Does not have an individual approval but may be used under an appropriate group standard
GefahrenübersichtA skin, respiratory tract, and strong eye irritant[Alfa Aesar MSDS]
Hazard Classes and CategoriesSkin Irrit. 2 (100%)
F10-23
Wassergefährdungsklasse (WGK)3
TSCA-Inventar-StatusTSCA listed
Zollcode29189900
R-Sätze (R)36/37/38
GefahrensymboleXi
Sicherheitshinweise (S)26-36
GefahrenklasseIRRITANT
Lagerklasse11 - Combustible Solids

Anwendungen & Verwendung

Beschreibung

Homovanillic acid (HVA) is a dopamine metabolite. It is formed via deamination of dopamine by monoamine oxidase (MAO) to produce 3,4-dihydroxyphenylacetic acid (DOPAC; ) followed by DOPAC metabolism by catechol-O-methyltransferase (COMT). HVA undergoes hydrogen peroxide-dependent oxidation in the presence of horseradish peroxidase to form a fluorescent dimer that displays excitation/emission maxima of 312/420 nm, respectively. It has been used to quantify hydrogen peroxide production in macrophages and neutrophils.

Verwenden

Fluorimetric reagent and major catecholamine metaboliteHomovanillic acid is used as a reagent in the determination of oxidative enzymes. It is associated with dopamine levels in the brain. Its presence supports a diagnosis of neuroblastoma and malignant pheochromocytoma.